| Structure | Chemical Name | CAS | MF |
|
N-[(1-ethyl-1H-pyrazol-4-yl)methyl]-N-methylamine
|
1002651-68-4
|
C7H13N3
|
|
N-ethyl-2-{[(2-naphthyloxy)acetyl]amino}benzamide
|
875060-41-6
|
C21H20N2O3
|
|
N-Ethyl-3,4-(methylenedioxy)aniline
|
32953-14-3
|
C9H11NO2
|
|
Alverine citrate
|
5560-59-8
|
C26H35NO7
|
|
Sultopride hydrochloride
|
23694-17-9
|
C17H27ClN2O4S
|
|
Ethalfluralin
|
55283-68-6
|
C13H14F3N3O4
|
|
2-Acetyl-1-ethylpyrrole
|
39741-41-8
|
C8H11NO
|
|
N-Ethylbenzimidazole
|
7035-68-9
|
C9H10N2
|
|
N-(2-Ethylhexyl)-5-norbornene-2,3-dicarboximide
|
113-48-4
|
C17H25NO2
|
|
Ethylurea
|
625-52-5
|
C3H8N2O
|
|
N-(4-Ethylenedioxycylohexyl)-1-amino-2,2-diethoxyethane
|
176492-83-4
|
C14H27NO4
|
|
Edrophonium chloride
|
116-38-1
|
C10H16ClNO
|
|
L-Theanine
|
34271-54-0
|
C7H14N2O3
|
|
1-Ethyl-2,3-dioxopiperazine
|
59702-31-7
|
C6H10N2O2
|
|
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[(3-methyl-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]acetamide
|
332937-66-3
|
C17H19N5O2S3
|
|
N-(2-ethylhexyl)-2-(1-naphthyloxy)acetamide
|
791841-28-6
|
C20H27NO2
|
|
N-(2-ethylphenyl)-3,4,5-trimethoxybenzamide
|
299950-95-1
|
C18H21NO4
|
|
N-(4-ethylphenyl)-2-{[6-({2-hydroxy-5-nitrobenzylidene}amino)-1,3-benzothiazol-2-yl]sulfanyl}acetamide
|
311783-03-6
|
C24H20N4O4S2
|
|
N-[4-(4-ethylphenyl)-1,3-thiazol-2-yl]-2-{4-nitrophenyl}acetamide
|
545441-90-5
|
C19H17N3O3S
|
|
N-(4-ethylphenyl)-2-[(2-hydroxyethyl)sulfanyl]acetamide
|
|
C12H17NO2S
|
|
N-[4-(ethyloxy)phenyl]-4-hydroxy-2-oxo-1-pentyl-1,2-dihydroquinoline-3-carboxamide
|
|
C23H26N2O4
|
|
N-ethyl-1-(4-methylphenyl)-5-oxo-3-pyrrolidinecarboxamide
|
|
C14H18N2O2
|
|
N-(5-ethyl-4-phenyl-1,3-thiazol-2-yl)-2-phenyl-4-quinolinecarboxamide
|
|
C27H21N3OS
|
|
N-(2-ethylphenyl)-10-phenyl-9-azatetracyclo[10.2.1.0~2,11~.0~3,8~]pentadeca-3,5,7-triene-5-carboxamide
|
1005111-98-7
|
C29H30N2O
|
|
N'-(1-ethylpropylidene)-2-phenylcyclopropanecarbohydrazide
|
438457-07-9
|
C15H20N2O
|
|
N-(2-ethylphenyl)-2-[2-methoxy-5-methyl(methylsulfonyl)anilino]acetamide
|
|
C19H24N2O4S
|
|
N-[4-(ethylsulfanyl)phenyl]-1-adamantanecarboxamide
|
519018-68-9
|
C19H25NOS
|
|
N-(2-ethylphenyl)-4-fluorobenzamide
|
349398-35-2
|
C15H14FNO
|
|
N-{4-(ethyloxy)-2-nitrophenyl}-3-[4-(methyloxy)phenyl]-1-phenyl-1H-pyrazole-4-carboxamide
|
492448-01-8
|
C25H22N4O5
|
|
N-(2-ethyl-6-methylphenyl)-2-(2-methylphenoxy)propanamide
|
875123-08-3
|
C19H23NO2
|
|
N-ethyl-N-(3-methylphenyl)amine hydrochloride
|
|
C9H14ClN
|
|
4-(N-Ethyl-N-benzyl)amino-benzoaldehyde
|
67676-47-5
|
C16H17NO
|
|
N-Ethyl-N-hydroxyethyl-4-amino-2-methyl benzaldehyde
|
21850-52-2
|
C12H17NO2
|
|
N-(6-Ethylthieno[2,3-d]pyrimidin-4-yl)glycine
|
313534-29-1
|
C10H11N3O2S
|
|
N-(4-ethylphenyl)-2-(2-thienyl)acetamide
|
349432-82-2
|
C14H15NOS
|
|
N-(2-ethylphenyl)-7-(trifluoromethyl)-5-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
|
313388-81-7
|
C25H23F3N4O4
|
|
Nestin
|
|
|
|
|
Nestifylline
|
|
|
|
|
NESTIN,CLONE:10C2,MABANTI-HUMAN:IB/IHC
|
|
|
|
|
nestin protein
|
|
|
|
|
NESTIN,CLONE:10C2,RABBITANTI-HUMAN:IB/IC/IHC
|
|
|
|
|
Nestle
|
|
|
|
Netivudine
|
84558-93-0
|
C12H14N2O6
|
|
|
Neu5Ac alpha(2-6)Gal beta(1-3)GlcNAc-beta-pNP
|
|
|
|
Neu5Ac alpha(2-3)Gal beta(1-4)GlcNAc-beta-pNP
|
501427-92-5
|
C31H45N3O21
|
|
NEU5AC ALPHA(2-3)GAL BETA MP GLYCOSIDE
|
159922-54-0
|
C24H35NO15
|
|
Neu5Ac alpha(2-6)Gal beta(1-4)GlcNAc-beta-pNP
|
501427-93-6
|
C31H45N3O21
|
|
Neu5Ac alpha(2-3)Gal beta(1-4)Glc-beta-pNP
|
2149582-14-7
|
C29H42N2O21
|
|
|
Neu5Ac[1Me,4789Ac]alpha(2-3)Gal[246Bz]-beta-MP
|
|
|
|
|
Neu5Ac alpha(2-6)GalNAc-alpha-pNP
|
|
|
|
|
Neu5Ac(a2-3)Gal(b1-3)GalNAc
|
|
C25H42N2O20
|
|
Neu5Ac2-β-3Gal1-β-4GlcNAc
|
210418-18-1
|
C25H42N2O19
|
|
|
Neu5Ac N-acetylgalactosamine 2,6-sialyltransferase
|
|
|
|
|
Neu5Aca26GalNAca1-O-Ser
|
|
|
|
|
NEU5ACB-METHYLGLYCOSIDE
|
|
|
|
|
NEU5AC,SIALICACID
|
|
|
|
|
NeuAcalpha2,3-Galbeta1,3-GalNAc-GalNAcalpha2,6-sialyltransferase IV
|
|
|
|
Neu5Aca2-3Galb1-3GlcN(Neu5Aca2-6)(Fuca1-4)Acb1-3Galb1-4Glc
|
127783-56-6
|
C54H89N3O41
|
|
|
NEU5ACALPHA2-6GALBETA1-4-GALNAC
|
|
|
|
|
NEU5ACMETHYLESTER,B-METHYLGLYCOSIDE
|
|
|
|
|
NEU-5AC-ALPHA(2,6)-GAL/GALNAC-SPECIFIC TYPE 2 RIP (SNAI)
|
|
|
|
Nestosyl ointment
|
80127-69-1
|
C35H39N3O8Zn
|
|
|
Nessy protein
|
|
|
|
|
NESTOSYLOIL
|
|
|
|
Nestoron
|
7759-35-5
|
C23H30O4
|
|
N-(estradiol-17 beta-succinylaminohexyl)-N'-fluoresceinyl-thiourea
|
78232-36-7
|
C49H53N3O9S
|
|
NF-kB Activation Inhibitor VI, BOT-64
|
113760-29-5
|
C15H15NO2S
|
|
|
NF-kB Antisense Oligonucleotide, Sodium Salt
|
|
|
|
|
NF-kB Antisense Oligo, Fluorescein-Labeled, Sodium Salt
|
|
|
|
|
NEU5ALPHA2-6GALBETA1-4GLC
|
|
|
|
|
NfkbC-RelSubunitControlPeptide
|
|
|
|
|
NG-Ab Casset
|
|
|
|
|
NfkbC-RelSubunit
|
|
|
|
N-[(E)-Styryl]acetamide
|
|
C10H11NO
|
|
|
NF-KAPPA-B CONSENSUS OLIGONUCLEOTIDE
|
|
|
|
|
NF-kappa B p105 precursor
|
|
|
|
|
NF-KAPPA-B, HUMAN, RECOMBINANT
|
|
|
|
|
NF-KAPPA-B OLIGONUCLEOTIDE
|
|
|
|
|
NF-kappaB Activation Inhibitor
|
|
|
|
|
NF-kappa B
|
|
|
|
|
NF-kappa B p50
|
|
|
|
|
NF-kappa B kinase
|
|
|
|
|
NF-kappa B p65
|
|
|
|
|
NF-KAPPA-B (P50) (HUMAN) (HIS)
|
|
|
|
NF-KAPPA-B SN50M, CELL-PERMEABLE INACTIVE CONTROL PEPTIDE
|
|
C123H215N33O30S
|
|
|
NF-KAPPA-B ANTISENSE OLIGONUCLEOTIDE, FLUORESCEIN-LABELED, SODIUM SALT
|
|
|
|
|
NF-KAPPA-B MUTANT OLIGONUCLEOTIDE
|
|
|
|
|
NF-KAPPA B INHIBITORY LIGAND
|
|
|
|
|
NF-kappaB Antibody Sampler Kit
|
|
|
|
NFKB INDUCING KINASE, HUMAN, C-TERM
|
|
C96H140N30O24
|
|
N-G-ACETYL-5-METHOXYKYNURENAMINE, HYDROCHLORIDE
|
|
C12H17ClN2O3
|
|
|
NEU,C-ERBB-2(ONCOGENEPROTEIN),CLONE:LY369,MABANTI-HUMAN
|
|
|
|
|
NF-KB (P50) HUMAN
|
|
|
|
|
NFKB (P65) CONTROL PEPTIDE HUMAN
|
|
|
|
|
NFKBp65(p65 NF-kappa B;p65NFKB)
|
|
|
|
|
NfkbP65(Rela)Subunit,C-Terminal
|
|
|
|
|
NfkbP52(Nfkb2)Subunit
|
|
|
|
|
NfkbP50(Nfkb1)Subunit
|
|
|
|
|
NfkbP65(Rela)Subunit,N-Terminal
|
|
|
|
|
NfkbP105Subunit
|
|
|